[1] Collins F S, Varmus H. A new initiative on precision medicine[J]. New England Journal of Medicine, 2015, 372(9):793-795.
[2] HM Government. Strategy for UK life sciences:one year on[EB/OL].[2012-12-31]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/36684/12-1346-strategy-for-uk-life-sciencesone-year-on.pdf.
[3] Ashley E A. The precision medicine initiative:A new national effort[J]. Journal of the American Medical Association, 2015, 313(21):2119-2120.
[4] Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations[J]. Nucleic Acids Research, 2014, 42:D1001-D1006.
[5] MacArthur J, Bowler E, Cerezo M, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)[J]. Nu-cleic Acids Research, 2017, 45(D1):D896-D901.
[6] National Human Genome Research Institute. eMERGE Phase 1 RFA[EB/OL].[2007-03-27]. http://grants.nih.gov/grants/guide/rfa-files/RFAHG-07-005.html.
[7] Gottesman O, Kuivaniemi H, Tromp G, et al. The Electronic Medical Records and Genomics (eMERGE) Network:Past, present, and future[J]. Genetics in Medicine, 2013, 15(10):761-771.
[8] National Human Genome Research Institute. eMERGE Phase Ⅱ RFA[EB/OL].[2011-07-06]. http://grants.nih.gov/grants/guide/rfa-files/RFAHG-10-009.html.
[9] eMERGE. PheKb:Phenotype knowledgeBase[EB/OL].[2016-03-28]. http://www.PheKb.org.
[10] Rasmussen-Torvik L J, Stallings S C, Gordon A S, et al. Design and anticipated outcomes of the eMERGE-PGx project:A multicenter pi-lot for preemptive pharmacogenomics in electronic health record sys-tems[J]. Clinical Pharmacology and Therapeutics, 2014, 96(4):482-489.
[11] Kullo I J, Haddad R, Prows C A, et al. Return of results in the genom-ic medicine projects of the eMERGE network[J]. Frontiers in Genet-ics, 2014, doi:10.3389/fgene.2014.00050.
[12] Bradfield J P, Taal H R, Timpson N J, et al. A genome-wide associa-tion meta-analysis identifies new childhood obesity loci[J]. Nature Ge-netics, 2012, 44(5):526-531.
[13] Manolio T A, Chisholm R L, Ozenberger B, et al. Implementing ge-nomic medicine in the clinic:The future is here[J]. Genetics in Medi-cine, 2013, 15(4):258-267.
[14] Weitzel K W, Alexander M, Bernhardt B A, et al. The IGNITE net-work:a model for genomic medicine implementation and research[J]. BMC Medical Genomics, 2016, 9(1), doi:10.1186/s12920-015-0162-5.
[15] Ritchie M D, Holzinger E R, Li R, et al. Methods of integrating data to uncover genotype-phenotype interactions[J]. Nature Reviews Genet-ics, 2015, 16(2):85-97.
[16] Vilhjalmsson B J, Nordborg M. The nature of confounding in genomewide association studies[J]. Nature Reviews Genetics, 2013, 14(1):1-2.
[17] Raychaudhuri S, Plenge R M, Rossin E J, et al. Identifying Relation-ships among genomic disease regions:Predicting genes at pathogenic snp associations and rare deletions[J]. PLoS Genetics, 2009, 5(6):e10005801.
[18] Crooke P S, Ritchie M D, Hachey D L, et al. Estrogens, enzyme vari-ants, and breast cancer:A risk model[J]. Cancer Epidemiology, Bio-markers & Prevention, 2006, 15(9):1620-1629.
[19] Sharaf R N, Butte A J, Montgomery K D, et al. Computational predic-tion and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes[J]. BMC Gastroenterology, 2011, 11(1):5.
[20] Maslove D M, Lamontagne F, Marshall J C, et al. A path to precision in the ICU[J]. Critical Care, 2017, 21(1):79.
[21] Lauer M S, D'Agostino R B, Sr. The randomized registry trial——the next disruptive technology in clinical research?[J]. New England Jour-nal of Medicine, 2013, 369(17):1579-1581.
[22] Frobert O, Lagerqvist B, Olivecrona G K, et al. Thrombus aspiration during ST-segment elevation myocardial infarction[J]. New England Journal of Medicine, 2013, 369(17):1587-1597.
[23] Zanetti R, Schmidtmann I, Sacchetto L, et al. Completeness and timeli-ness:Cancer registries could/should improve their performance[J]. Eu-ropean Journal of Cancer, 2015, 51(9):1091-1098.
[24] 冯时, 弓孟春, 张抒扬. 中国国家罕见病注册系统及其队列研究:愿景与实施路线[J]. 中华内分泌代谢杂志, 2016, 32(12):977-982. Feng Shi, Gong Mengchun, Zhang Shuyang. The national rare diseases registry system of China and the related cohorts studies:Vision and roadmap[J]. Chinese Journal of Endocrinology and Metabolism, 2016, 32(12):977-982.
[25] Iyer G, Hanrahan A J, Milowsky M I, et al. Genome sequencing identi-fies a basis for everolimus sensitivity[J]. Science, 2012, 338(6104):221.
[26] Holroyd-Leduc J M, Lorenzetti D, Straus S E, et al. The impact of the electronic medical record on structure, process, and outcomes within primary care:a systematic review of the evidence[J]. Journal of the American Medical Informatics Association, 2011, 18(6):732-737.
[27] Castaneda C, Nalley K, Mannion C, et al. Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine[J]. Journal of Clinical Bioinformatics, 2015, 5(1):4.
[28] Chabra S. International Classification of Diseases, 10th Revision, cod-ing for prematurity:Need for standardized nomenclature[J]. The Health Care Manager, 2015, 34(2):123-127.
[29] Millar J. The Need for a Global Language-SNOMED CT Introduction[J]. Studies in Health Technology and Informatics, 2016, 225:683-685.
[30] Robinson P N, Mundlos S. The human phenotype ontology[J]. Clinical Genetics, 2010, 77(6):525-534.
[31] Chinese Human Phenotype Ontology Consortium. CHPO[DB/OL].[2017-03-31]. http://wiki.chinahpo.org/index.php/CHPO.
[32] Schiff G D, Hasan O, Kim S, et al. Diagnostic error in medicine:Anal-ysis of 583 physician-reported errors[J]. Archives of Internal Medi-cine, 2009, 169(20):1881-1887.
[33] Singh H, Giardina T D, Meyer A N D, et al. Types and Origins of Di-agnostic Errors in Primary Care Settings[J]. JAMA Internal Medicine, 2013, 173(6):418-425.
[34] Osheroff J A, Teich J M, Middleton B, et al. A roadmap for national action on clinical decision support[J]. Journal of the American Medi-cal Informatics Association, 2007, 14(2):141-145.
[35] Kuperman G J, Bobb A, Payne T H, et al. Medication-related clinical decision support in computerized provider order entry systems:A re-view[J]. Journal of the American Medical Informatics Association, 2007, 14(1):29-40.
[36] 弓孟春, 王慧君, 卢宇蓝, 等. 药物基因组学临床部署的顶层设计[J]. 中国循证儿科杂志, 2016(3):161-167. Gong Mengchun, Wang Huijun, Lu Yulan, et al. Design of Clinical Practice of Pharmacogenomics[J]. Chinese Journal of Evidence-Based Pediatrics, 2016(3):161-167.
[37] Caudle K E, Klein T E, Hoffman J M, et al. Incorporation of pharma-cogenomics into routine clinical practice:The Clinical Pharmacogenet-ics Implementation Consortium (cpic) guideline development process[J]. Current Drug Metabolism, 2014, 15(2):209-217.
[38] Hoffman J M, Dunnenberger H M, Kevin Hicks J, et al. Developing knowledge resources to support precision medicine:principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)[J]. Journal of the American Medical Informatics Association, 2016, 23(4):796-801.
[39] Graber M L, Franklin N, Gordon R. Diagnostic error in internal medi-cine[J]. Archives of Internal Medicine, 2005, 165(13):1493-1499.
[40] Ormond K E, Cho M K. Translating personalized medicine using new genetic technologies in clinical practice:The ethical issues[J]. Person-alized Medicine, 2014, 11(2):211-222.
[41] Fiore R N, Goodman K W. Precision medicine ethics:selected issues and developments in next-generation sequencing, clinical oncology, and ethics[J]. Current Opinion in Oncology, 2016, 28(1):83-87.
[42] McGowan M L, Settersten R A, Juengst E T, et al. Integrating genom-ics into clinical oncology:Ethical and social challenges from propo-nents of personalized medicine[J]. Urologic Oncology-Seminars And Original Investigations, 2014, 32(2):187-192.
[43] Hazin R, Brothers K B, Malin B A, et al. Ethical, legal, and social im-plications of incorporating genomic information into electronic health records[J]. Genetics in Medicine, 2013, 15(10):810-816.
[44] Green R C, Berg J S, Grody W W, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequenc-ing[J]. Genetics in Medicine, 2013, 15(7):565-574.
[45] Directors A B o. ACMG policy statement:Updated recommendations regarding analysis and reporting of secondary findings in clinical ge-nome-scale sequencing[J]. Genetics in Medicine, 2015, 17(1):68-69.
[46] Jarvik G P, Amendola L M, Berg J S, et al. Return of genomic results to research participants:The floor, the ceiling, and the choices in be-tween[J]. American Journal of Human Genetics, 2014, 94(6):818-826.
[47] Middleton A, Morley K I, Bragin E, et al. No expectation to share inci-dental findings in genomic research[J]. The Lancet, 2015, 385(9975):1289-1290.
[48] Weiner C. Anticipate and communicate:Ethical management of inci-dental and secondary findings in the clinical, research, and direct-toconsumer contexts (December 2013 report of the Presidential Commis-sion for the Study of Bioethical Issues)[J]. American Journal of Epide-miology, 2014, 180(6):562-564.
[49] Murphy Bollinger J, Bridges J F, Mohamed A, et al. Public preferenc-es for the return of research results in genetic research:A conjoint analysis[J]. Genetics in Medicine, 2014, 16(12):932-939.
[50] Bombard Y. Translating personalized genomic medicine into clinical practice:evidence, values, and health policy[J]. Genome, 2015, 58(12):491-497.
[51] Green R C, Lautenbach D, McGuire A L. GINA, genetic discrimina-tion, and genomic medicine[J]. New England Journal of Medicine, 2015, 372(5):397-399.
[52] Vassy J L, Lautenbach D M, McLaughlin H M, et al. The MedSeq Project:a randomized trial of integrating whole genome sequencing in-to clinical medicine[J]. Trials, 2014, doi:10.1186/1745-6215-15-85.
[53] Bombard Y, Rozmovits L, Trudeau M E, et al. Patients' perceptions of gene expression profiling in breast cancer treatment decisions[J]. Cur-rent Oncology, 2014, 21(2):E203-E211.
[54] Torjesen I. Genomes of 100000 people will be sequenced to create an open access research resource[J]. BMJ, 2013, doi:10.1136/bmj.f6690.
[55] Bonter K, Desjardins C, Currier N, et al. Personalised medicine in Canada:A survey of adoption and practice in oncology, cardiology and family medicine[J]. BMJ Open, 2011, 1(1):e000110.
[56] Demmer L A, Waggoner D J. Professional medical education and ge-nomics[J]. Annual Review of Genomics and Human Genetics, 2014, 15:507-516.
[57] Korf B R. Genetics and genomics education:the next generation[J]. Ge-netics in Medicine, 2011, 13(3):201-202.
[58] Crawford D C, Crosslin D R, Tromp G, et al. eMERGEing progress in genomics-the first seven years[J]. Frontiers in Genetics, 2014, 5:184.
[59] Kho A N, Hayes M G, Rasmussen-Torvik L, et al. Use of diverse elec-tronic medical record systems to identify genetic risk for type 2 diabe-tes within a genome-wide association study[J]. Journal of the Ameri-can Medical Informatics Association, 2012, 19(2):212-218.
[60] Sperber N R, Carpenter J S, Cavallari L H, et al. Challenges and strat-egies for implementing genomic services in diverse settings:experienc-es from the Implementing GeNomics In pracTicE (IGNITE) network[J]. BMC Medical Genomics, 2017, 10(1):35
